Vaginal micronized progesterone versus the levonorgestrel‐releasing intrauterine system for treatment of non‐atypical endometrial hyperplasia: A randomized controlled trial-Reference-Cited by-同舟云学术

Vaginal micronized progesterone versus the levonorgestrel‐releasing intrauterine system for treatment of non‐atypical endometrial hyperplasia: A randomized controlled trial

Published:2023-01-12 Issue:2 Volume:161 Page:661-666
ISSN:0020-7292
Container-title:International Journal of Gynecology & Obstetrics
language:en
Short-container-title:Intl J Gynecology & Obste

Author:

Gezer Şener¹^ORCID,Köle Emre²^ORCID,Aksoy Lale³^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology Kocaeli University School of Medicine Kocaeli Turkey

2. Department of Obstetrics and Gynecology Alanya Alaaddin Keykubat University School of Medicine Alanya Turkey

3. Department of Obstetrics and Gynecology Geyve State Hospital Geyve Turkey

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijgo.14632

Reference22 articles.

1. The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women

2. The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia

3. Levonorgestrel-Releasing Intrauterine Device Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

4. Levonorgestrel‐releasing intrauterine system for endometrial hyperplasia;Mittermeier T;Cochrane Database Syst Rev,2020

5. Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaginal micronized progesterone in treating endometrial hyperplasia without atypia;Annals of Clinical and Analytical Medicine;2023